Veldhuizen G, Alnazer R, de Leeuw P, Kroon A
Cardiovasc Drugs Ther. 2021; 37(2):283-289.
PMID: 34515895
PMC: 10014657.
DOI: 10.1007/s10557-021-07262-3.
Song C, Ghafoor K, Ghafoor H, Khan N, Thirunavukkarasu S, Jennings B
Hypertension. 2015; 67(1):206-13.
PMID: 26573711
PMC: 4672747.
DOI: 10.1161/HYPERTENSIONAHA.115.06427.
OBoyle C, Laher M, OBrien E, OMalley K, Kelly J
Eur J Clin Pharmacol. 1982; 23(2):93-7.
PMID: 6754385
DOI: 10.1007/BF00545961.
Freslon J, Giudicelli J
Br J Pharmacol. 1983; 80(3):533-43.
PMID: 6357337
PMC: 2045007.
DOI: 10.1111/j.1476-5381.1983.tb10726.x.
Luscher T, Havelka J, Greminger P, Tuma J, Tauber M, Siegenthaler W
Eur J Clin Pharmacol. 1982; 23(5):411-5.
PMID: 6129980
DOI: 10.1007/BF00605990.
[Plasma renin activity after the injection of orthortase and diazoxide in primary and renal hypertension].
Klaus D, Schmelzle R, Simsch A, Trubestein G
Klin Wochenschr. 1970; 48(17):1033-40.
PMID: 5523458
DOI: 10.1007/BF01497208.
Studies on patients with renal artery stenosis (the diagnostic value of plasma renin activity measurements).
KIRKENDALL W, Kioschos J
Trans Am Clin Climatol Assoc. 1970; 82:101-13.
PMID: 4934013
PMC: 2441031.
[Plasma renin activity in venous renal blood and its stimulation by hydralazine and theophylline (author's transl)].
Klumpp F, Klaus D, Rossler R, Sadowski P
Klin Wochenschr. 1973; 51(17):875-82.
PMID: 4746367
DOI: 10.1007/BF01467740.
[Importance of the sympathico-adrenal system in renin release].
MEURER K
Klin Wochenschr. 1971; 49(18):1001-14.
PMID: 4328546
DOI: 10.1007/BF01487731.
The pharmacokinetics and haemodynamics of BTS 49 465 and its major metabolite in healthy volunteers.
Wynne R, Crampton E, Hind I
Eur J Clin Pharmacol. 1985; 28(6):659-64.
PMID: 3905414
DOI: 10.1007/BF00607911.
Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.
Mulrow J, Crawford M
Clin Pharmacokinet. 1989; 16(2):86-9.
PMID: 2656046
DOI: 10.2165/00003088-198916020-00003.
Stimulation of renin secretion by various methods: optional results with hydrochlorothiazide.
Traub Y, Nemes L, ALOOF S, Rosenfeld J
Int Urol Nephrol. 1976; 8(3):247-55.
PMID: 1002400
DOI: 10.1007/BF02082246.
The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension.
Werning C
Klin Wochenschr. 1976; 54(15):727-34.
PMID: 790007
DOI: 10.1007/BF01470464.
Effect of antihypertensive drugs on the renin-angiotensin system.
Johnston C
Drugs. 1976; 12(4):274-91.
PMID: 786609
DOI: 10.2165/00003495-197612040-00003.
Increased levels of prostaglandin-like material in the canine blood during arterial hypotension produced by hydralazine, dihydralazine and minoxidil.
Haeusler G, GEROLD M
Naunyn Schmiedebergs Arch Pharmacol. 1979; 310(2):155-67.
PMID: 530321
DOI: 10.1007/BF00500280.
Need for beta-blockade in hypertension reduced with long-term minoxidil.
Brunner H, Jaeger P, Ferguson R, Jequier E, Turini G, Gavras H
Br Med J. 1978; 2(6134):385-8.
PMID: 28811
PMC: 1609020.
DOI: 10.1136/bmj.2.6134.385.
